STOCK TITAN

[144] Alector, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Alector, Inc. (ALEC) Form 144 notice shows that 23,019 shares of Common Stock (aggregate market value $54,094.65) are proposed to be sold through Morgan Stanley Smith Barney on 09/02/2025 on Nasdaq. The shares were acquired on 08/29/2025 by vesting of restricted stock units from the issuer, with 45,330 RSU units recorded as acquired that date. The filing also discloses a prior sale by the same person: 23,890 shares sold on 06/02/2025 for $31,974.38. The notice includes the standard representation that the seller is not aware of any undisclosed material adverse information about the issuer.

Alector, Inc. (ALEC) Avviso Form 144 indica che sono proposte in vendita 23.019 azioni di Common Stock (valore di mercato complessivo $54.094,65) tramite Morgan Stanley Smith Barney il 02/09/2025 sul Nasdaq. Le azioni sono state acquisite il 29/08/2025 mediante la maturazione di unità azionarie vincolate (RSU), con 45.330 RSU registrate come acquisite in quella data. Il documento segnala inoltre una vendita precedentemente effettuata dalla stessa persona: 23.890 azioni vendute il 02/06/2025 per $31.974,38. L'avviso contiene la consueta dichiarazione secondo cui il venditore non è a conoscenza di informazioni materiali sfavorevoli non divulgate sull'emittente.

Alector, Inc. (ALEC) Aviso Form 144 informa que se propone vender 23.019 acciones de Common Stock (valor de mercado agregado $54.094,65) a través de Morgan Stanley Smith Barney el 02/09/2025 en Nasdaq. Las acciones fueron adquiridas el 29/08/2025 por la consolidación de unidades restringidas de acciones (RSU), registrándose 45.330 RSU como adquiridas en esa fecha. La presentación también revela una venta previa de la misma persona: 23.890 acciones vendidas el 02/06/2025 por $31.974,38. El aviso incluye la declaración estándar de que el vendedor no conoce información desfavorable material no divulgada sobre el emisor.

Alector, Inc. (ALEC) Form 144 공지에 따르면 Common Stock 23,019주(총 시가 $54,094.65)가 2025-09-02 나스닥에서 Morgan Stanley Smith Barney를 통해 매도될 예정입니다. 해당 주식은 발행사로부터의 제한주식단위(RSU) 베스팅으로 2025-08-29에 취득되었으며, 그날 45,330 RSU가 취득된 것으로 기록되어 있습니다. 제출서류에는 동일 인물의 이전 매도도 공개되어 있는데, 23,890주2025-06-02에 $31,974.38에 매도되었습니다. 공지문에는 매도인이 발행사에 관해 공개되지 않은 중대한 불리한 정보가 없음을 알고 있지 않다는 표준 진술도 포함되어 있습니다.

Alector, Inc. (ALEC) Avis Form 144 indique que 23 019 actions de Common Stock (valeur de marché totale $54 094,65) sont proposées à la vente via Morgan Stanley Smith Barney le 02/09/2025 sur le Nasdaq. Les actions ont été acquises le 29/08/2025 par l'acquisition par vesting d'unités d'actions restreintes (RSU), 45 330 RSU ayant été enregistrées comme acquises à cette date. Le dépôt révèle également une vente antérieure par la même personne : 23 890 actions vendues le 02/06/2025 pour $31 974,38. L'avis inclut la déclaration standard selon laquelle le vendeur n'a connaissance d'aucune information défavorable importante non divulguée concernant l'émetteur.

Alector, Inc. (ALEC) Form 144-Mitteilung zeigt, dass 23.019 Aktien der Common Stock (gesamt Marktwert $54.094,65) über Morgan Stanley Smith Barney am 02.09.2025 an der Nasdaq zum Verkauf angeboten werden sollen. Die Aktien wurden am 29.08.2025 durch die Vesting von Restricted Stock Units (RSU) erworben; an diesem Datum wurden 45.330 RSU als erworben verbucht. Die Einreichung offenbart außerdem einen vorherigen Verkauf derselben Person: 23.890 Aktien verkauft am 02.06.2025 für $31.974,38. Die Mitteilung enthält die übliche Erklärung, dass der Verkäufer keine Kenntnis von nicht offengelegten, wesentlichen nachteiligen Informationen über den Emittenten hat.

Positive
  • Clear compliance with Rule 144 procedures by identifying broker, sale date, and share quantities
  • Disclosure of acquisition details showing shares were acquired via vesting of RSUs on 08/29/2025
  • Prior recent sale disclosed (23,890 shares sold on 06/02/2025 for $31,974.38), improving transparency
Negative
  • None.

Insights

TL;DR: Routine Rule 144 notice for vested RSUs and a small proposed market sale; immaterial to capitalization.

The filing documents a proposed sale of 23,019 shares valued at $54,094.65 and discloses a recent sale of 23,890 shares for $31,974.38. The securities were acquired by vesting of restricted stock units on 08/29/2025. Given the issuer's reported outstanding shares of 101,212,329, the proposed sale represents a de minimis portion of the float and is unlikely to move market valuation. The use of a broker (Morgan Stanley Smith Barney) and the Rule 144 framework indicate the seller is following standard resale procedures.

TL;DR: Disclosure aligns with compliance expectations; provides transparency on insider vesting and resale activity.

The form identifies the nature of acquisition as vesting of RSUs and specifies acquisition and payment dates (08/29/2025). It also contains the seller's signed representation about absence of undisclosed material adverse information and references potential trading-plan disclosures. This level of detail meets typical governance and disclosure standards for officer/director/affiliate transfers under Rule 144.

Alector, Inc. (ALEC) Avviso Form 144 indica che sono proposte in vendita 23.019 azioni di Common Stock (valore di mercato complessivo $54.094,65) tramite Morgan Stanley Smith Barney il 02/09/2025 sul Nasdaq. Le azioni sono state acquisite il 29/08/2025 mediante la maturazione di unità azionarie vincolate (RSU), con 45.330 RSU registrate come acquisite in quella data. Il documento segnala inoltre una vendita precedentemente effettuata dalla stessa persona: 23.890 azioni vendute il 02/06/2025 per $31.974,38. L'avviso contiene la consueta dichiarazione secondo cui il venditore non è a conoscenza di informazioni materiali sfavorevoli non divulgate sull'emittente.

Alector, Inc. (ALEC) Aviso Form 144 informa que se propone vender 23.019 acciones de Common Stock (valor de mercado agregado $54.094,65) a través de Morgan Stanley Smith Barney el 02/09/2025 en Nasdaq. Las acciones fueron adquiridas el 29/08/2025 por la consolidación de unidades restringidas de acciones (RSU), registrándose 45.330 RSU como adquiridas en esa fecha. La presentación también revela una venta previa de la misma persona: 23.890 acciones vendidas el 02/06/2025 por $31.974,38. El aviso incluye la declaración estándar de que el vendedor no conoce información desfavorable material no divulgada sobre el emisor.

Alector, Inc. (ALEC) Form 144 공지에 따르면 Common Stock 23,019주(총 시가 $54,094.65)가 2025-09-02 나스닥에서 Morgan Stanley Smith Barney를 통해 매도될 예정입니다. 해당 주식은 발행사로부터의 제한주식단위(RSU) 베스팅으로 2025-08-29에 취득되었으며, 그날 45,330 RSU가 취득된 것으로 기록되어 있습니다. 제출서류에는 동일 인물의 이전 매도도 공개되어 있는데, 23,890주2025-06-02에 $31,974.38에 매도되었습니다. 공지문에는 매도인이 발행사에 관해 공개되지 않은 중대한 불리한 정보가 없음을 알고 있지 않다는 표준 진술도 포함되어 있습니다.

Alector, Inc. (ALEC) Avis Form 144 indique que 23 019 actions de Common Stock (valeur de marché totale $54 094,65) sont proposées à la vente via Morgan Stanley Smith Barney le 02/09/2025 sur le Nasdaq. Les actions ont été acquises le 29/08/2025 par l'acquisition par vesting d'unités d'actions restreintes (RSU), 45 330 RSU ayant été enregistrées comme acquises à cette date. Le dépôt révèle également une vente antérieure par la même personne : 23 890 actions vendues le 02/06/2025 pour $31 974,38. L'avis inclut la déclaration standard selon laquelle le vendeur n'a connaissance d'aucune information défavorable importante non divulguée concernant l'émetteur.

Alector, Inc. (ALEC) Form 144-Mitteilung zeigt, dass 23.019 Aktien der Common Stock (gesamt Marktwert $54.094,65) über Morgan Stanley Smith Barney am 02.09.2025 an der Nasdaq zum Verkauf angeboten werden sollen. Die Aktien wurden am 29.08.2025 durch die Vesting von Restricted Stock Units (RSU) erworben; an diesem Datum wurden 45.330 RSU als erworben verbucht. Die Einreichung offenbart außerdem einen vorherigen Verkauf derselben Person: 23.890 Aktien verkauft am 02.06.2025 für $31.974,38. Die Mitteilung enthält die übliche Erklärung, dass der Verkäufer keine Kenntnis von nicht offengelegten, wesentlichen nachteiligen Informationen über den Emittenten hat.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for Alector (ALEC) disclose about the proposed sale?

The form discloses a proposed sale of 23,019 shares of Common Stock through Morgan Stanley Smith Barney on 09/02/2025 with an aggregate market value of $54,094.65.

How were the shares being sold acquired according to the filing?

The shares were acquired on 08/29/2025 by the vesting of restricted stock units from the issuer; 45,330 units are listed as acquired.

Did the filer disclose any recent sales of the issuer's stock?

Yes. The filing shows Sara Kenkare-Mitra sold 23,890 shares on 06/02/2025 for $31,974.38.

On which exchange and through which broker is the proposed sale to occur?

The proposed sale is to occur on Nasdaq through Morgan Stanley Smith Barney LLC Executive Services.

Does the filing state whether the seller knows of any undisclosed material information?

Yes. By signing the notice the seller represents they do not know any material adverse information
Alector

NASDAQ:ALEC

ALEC Rankings

ALEC Latest News

ALEC Latest SEC Filings

ALEC Stock Data

242.91M
90.58M
10.48%
77.09%
5.61%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO